Please login to the form below
Bioequivalence study triggers milestone payment for Eurand
Eurand completes a bioequivalence study with GlaxoSmithKline regarding an undisclosed GSK compound
Eurand, an Italian/ US-based specialty pharmaceutical company, has successfully completed a bioequivalence study with GlaxoSmithKline (GSK), regarding an undisclosed GSK compound.
UK-headquartered GSK will make a payment of USD 1.5m to Eurand in recognition of the milestone.
The new formulation, which uses Eurand's Microcaps and AdvaTab technologies, is designed to dissolve quickly in the mouth to reduce the bitter taste of some medications. Eurand could potentially receive milestone payments from GSK totalling up to USD 42m for the development of the product. GSK expects to file an NDA in the near future.
Under the agreement, Eurand will manufacture the product for GSK and receive royalty revenues when the product receives NDA approval from the FDA.
Gearoid Faherty, CEO of Eurand, said: "We are delighted with the results of the bio-study and are looking forward to GSK submitting their NDA."
Share
Related Hub content
Featured jobs
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
- Science Writer – Healthcare Advertising
-
Salary TBC
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Account Director, Training & Medical Communications, London
-
Competitive Salary
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Moving annual total (MAT)
- Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat
- Key success factor (KSF)
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- PEGASUS OPENS THE HEALTHCARE INSIGHTS STAGE AT CANNES LIONS
- May earmarks £20bn for the NHS - but experts say it's not enough
- Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more
- New trial results suggest CAR-T effects are durable in lymphoma
- Evotec says Sanofi deal makes it anti-infectives powerhouse
- Medicen Paris Region appoints new CEO
PMHub
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...
Latest intelligence
- Australian Flu and the dilemma of naming diseases
- ...
- Wearables and Healthcare
- What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
- What does a future-proof rep look like?
- Businesses can no longer afford to push ahead with the traditional Key Account Management model....
Quick links
Infographics
